Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningBone MarrowTransplantation, AutologousBone Marrow CellsWhole-Body IrradiationHematologic NeoplasmsTransplantation ChimeraTissue DonorsLiver TransplantationStem Cell TransplantationHistocompatibility TestingMyeloablative AgonistsGraft SurvivalHistocompatibilityLeukemiaBusulfanHematopoietic Stem CellsTreatment OutcomeAnemia, AplasticUnrelated DonorsKidney TransplantationPeripheral Blood Stem Cell TransplantationRecurrenceBone and BonesLeukemia, Myeloid, AcuteImmunosuppressive AgentsSyndromeRetrospective StudiesRemission InductionCord Blood Stem Cell TransplantationGraft RejectionGraft vs Tumor EffectHematopoiesisCyclophosphamideMyelodysplastic SyndromesSurvival AnalysisHLA AntigensCombined Modality TherapyTime FactorsTransplantation ImmunologyTransplantation, IsogeneicGraft vs Leukemia EffectLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingHeart TransplantationVidarabineChimerismSurvival RateAcute DiseaseHematologic DiseasesHepatic Veno-Occlusive DiseaseCell TransplantationImmunosuppressionDisease-Free SurvivalMice, Inbred C57BLLung TransplantationLymphoma, Non-HodgkinSiblingsCyclosporineFollow-Up StudiesLymphocyte DepletionT-LymphocytesBone Marrow DiseasesLymphocyte TransfusionTransplantationLeukemia, MyeloidMultiple MyelomaSevere Combined ImmunodeficiencyOrgan TransplantationRadiation ChimeraCytomegalovirus InfectionsDonor SelectionAntineoplastic Combined Chemotherapy ProtocolsAntilymphocyte SerumLiving DonorsBone Marrow ExaminationColony-Forming Units AssayAntigens, CD34Cell DifferentiationIslets of Langerhans TransplantationPrognosisRisk FactorsMinor Histocompatibility AntigensGraft vs Host ReactionLeukocyte TransfusionMelphalanLymphomaHodgkin DiseaseFlow CytometryPancreas TransplantationChimeraBone Marrow NeoplasmsInfectionBone RemodelingHematopoietic Stem Cell Mobilization